兔抗AMZ1多克隆抗體

Background:

AMZ1 shares sequence similarity with archaeal metalloproteases called archaemetzincins, but it appears to act predominantly as a basic aminopeptidase. Inhibited by the general metalloprotease inhibitors o-phenanthroline and batimastat. Also significantly inhibited by amastatin, which is an inhibitor of aminopeptidases. Not inhibited by 4-(2-aminoethyl)-benzenesulfonyl fluoride, E-64, and TIMPS (tissue inhibitors of metalloproteinases), which are inhibitors of serine, cysteine, and matrix metalloproteases, respectively.

Applications:

ELISA, WB, IHC

Name of antibody:

AMZ1

Immunogen:

Synthetic peptide of human AMZ1

Full name:

archaelysin family metallopeptidase 1

SwissProt:

Q400G9

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human brain

IHC Recommend dilution:

50-200

WB Predicted band size:

55 kDa

WB Positive control:

Human fetal brain and liver tissue

WB Recommended dilution:

500-2000